Estrella Immunopharma, Inc. (ESLA)

NASDAQ: ESLA · IEX Real-Time Price · USD
-0.11 (-8.40%)
At close: Dec 7, 2023, 3:59 PM
-0.05 (-4.17%)
After-hours: Dec 7, 2023, 7:30 PM EST
Market Cap 50.34M
Revenue (ttm) n/a
Net Income (ttm) -7.49M
Shares Out 35.20M
EPS (ttm) -2.92
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 41,047
Open 1.30
Previous Close 1.31
Day's Range 1.02 - 1.36
52-Week Range 1.02 - 33.00
Beta -0.09
Analysts n/a
Price Target n/a
Earnings Date Dec 19, 2023

About ESLA

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Est... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Country United States
Stock Exchange NASDAQ
Ticker Symbol ESLA
Full Company Profile

Financial Performance

Financial Statements


TradeUP Acquisition Corp. and Estrella Biopharma, Inc. Announce Completion of Business Combination

Estrella to Begin Trading on NASDAQ Under the Ticker Symbols "ESLA" and "ESLAW" Beginning October 2, 2023 NEW YORK , Sept. 29, 2023 /PRNewswire/ -- Estrella Immunopharma, Inc., formerly known as Trade...

2 months ago - PRNewsWire

TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination

NEW YORK , Sept. 18, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ: UPTD) today announced that, in order to extend the date by which the Company must complete its...

2 months ago - PRNewsWire

Estrella Biopharma, Inc., a biopharmaceutical company to Become a Publicly Traded Company Via Merger with TradeUP Acquisition Corp.

NEW YORK, Oct. 3, 2022 /PRNewswire/ -- Estrella Biopharma, Inc. ("Estrella"), a preclinical-stage biopharmaceutical company focusing on cancer therapeutics, and TradeUP Acquisition Corp. ("TradeUP") (...

1 year ago - PRNewsWire